Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
6 Currently, no cure exists for IBD, and treatment focuses on achieving and sustaining remission of inflammatory flares
- July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has received its production run of approximately 20,000 units of its BPC-157 transdermal patch (the "Patch"), the Company's lead product candidate
Important: These represent findings from controlled animal research studies and limited experimental reports
Athletes and active adults with stubborn connective tissue injuries tendinopathy, ligament sprains, or muscle tears that arent responding to PT or rest People managing chronic gut inflammation those dealing with GI issues, barrier dysfunction, or ulcer-related symptoms looking for adjunctive support Post-surgical patients seeking to optimize tissue healing and reduce inflammatory burden during recovery (with surgeon clearance) Wellness-focused individuals in the Johnson City and Tri-Cities area who are actively managing their health and want access to emerging regenerative options under medical supervision Biohackers and longevity-focused adults who have researched peptide therapy and want a provider with clinical oversight, verified compound sourcing, and a personalized protocol not a random online seller People already on complementary therapies like hormone optimization, IV therapy, or GLP-1 therapy who want to stack recovery tools strategically Multi-Site Recovery
US$ 29.41
US$ 24.18
US$ 28.28
US$ 20.71
US$ 24.53
US$ 20.34